- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03314480
REDucing Unnecessary Computed Tomography Imaging for MaxillOfacial INjury (REDUCTION)
May 20, 2022 updated by: Romke Rozema, University Medical Center Groningen
A Novel Clinical Decision Aid for the Diagnostic Management of Maxillofacial Trauma: the REDUCTION Trial - REDucing Unnecessary Computed Tomography Imaging for MaxillOfacial INjury
The aim is to prospectively assess the association between clinical parameters and the presence of maxillofacial fractures in trauma patients admitted to the emergency department.
Our hypothesis is that a clinical decision aid of critical parameters reduces unnecessary produced CT scans in maxillofacial trauma patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The REDUCTION trial is a prospective multicentre cohort study conducted at the level I emergency departments of the University Medical Center Groningen, Isala hospital (Zwolle, The Netherlands) and the level II trauma center Nij Smellinghe hospital (Drachten, The Netherlands).
The increased availability of Computed Tomography (CT) in the emergency department is leading to an overuse for patients with suspected maxillofacial injury.
The use of a clinical decision aid could lead to more expedient use of diagnostic imaging within this population of patients.
Therefore, all maxillofacial trauma patients admitted to the emergency department are included in this trial if the consultation is within 7 days after trauma.
Both maxillofacial trauma patients admitted to CT scan and patients without a radiological confirmed diagnosis are included.
The research protocol was approved by the institutional review board of the University Medical Center Groningen (Groningen, The Netherlands).
Informed consent was waived as patients are treated according to the standards of care.
Upon admission, each patient with maxillofacial injury will be allocated as a midfacial or mandibular trauma.
During physical examination, either by the emergency physician or surgical resident, a pre-defined selection of clinical parameters will be assessed focussing on the assessment of potential presence of fractures in the maxillofacial region.
The standardization of this examination will be ensured using a pocket map and easy accessible online instructional video's.
The clinical parameters, fracture likelihood and physical examination findings will be structurally reported in electronic health record software using a smart tool dedicated for maxillofacial injury.
Data regarding patient demographics, mechanism of injury, concomitant injury, diagnostic outcome and radiation dose parameters will be derived from the medical records.
Study Type
Observational
Enrollment (Actual)
1126
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Groningen, Netherlands, 9713 GZ
- University Medical Center Groningen, University of Groningen
-
-
Friesland
-
Drachten, Friesland, Netherlands, 9202 NN
- Nij Smellinghe Ziekenhuis
-
-
Overijssel
-
Meppel, Overijssel, Netherlands, 7943 KA
- Isala Diaconessenhuis
-
Zwolle, Overijssel, Netherlands, 8000 GK
- Isala Ziekenhuis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients with a maxillofacial trauma admitted to the emergency department of the cooperating hospitals
Description
Inclusion Criteria:
- consultation within 7 days of trauma
Exclusion Criteria:
- history of maxillofacial surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Midfacial fracture suspected patients
Patients who are suspected of maxillofacial fracture
|
Standarized physical examination dedicated to assess a potential fracture in the maxillofacial or mandibular region.
|
Mandibular fracture suspected patients
Patients who are suspected of a mandibular fracture
|
Standarized physical examination dedicated to assess a potential fracture in the maxillofacial or mandibular region.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maxillofacial fracture
Time Frame: Within 1 day, from admission to discharge from the emergency department
|
The presence of either a maxillofacial or mandibular fracture induced by the trauma and diagnosed using CT or orthopantomography in the emergency department.
|
Within 1 day, from admission to discharge from the emergency department
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment outcome
Time Frame: Within 2 weeks upon admission to the emegency department
|
The outcome of the treatment as determined by the Oral and Maxillofacial (OMF) surgeon or emergency physician classified as;
|
Within 2 weeks upon admission to the emegency department
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
CT time
Time Frame: Within 2 weeks from admission to the emergency department
|
Time from admission to CT scanner
|
Within 2 weeks from admission to the emergency department
|
Emergency department total time of admission
Time Frame: Within 2 weeks from admission to the emergency department
|
Total time the patient was of admitted at the emergency department
|
Within 2 weeks from admission to the emergency department
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Fred KL Spijkervet, DMD PhD, University of Groningen
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Rozema R, Moumni ME, de Vries GT, Spijkervet FKL, Verbeek R, Kleinbergen JYJ, Bens BWJ, Doff MHJ, van Minnen B; REDUCTION study group. A clinical decision aid for patients with suspected midfacial and mandibular fractures (the REDUCTION-I study): a prospective multicentre cohort study. Eur J Trauma Emerg Surg. 2022 Oct;48(5):4243-4254. doi: 10.1007/s00068-022-01968-1. Epub 2022 Apr 16.
- Rozema R, El Moumni M, de Vries GT, Spijkervet FKL, Verbeek R, Kleinbergen JYJ, Bens BWJ, Doff MHJ, van Minnen B; REDUCTION study group. A clinical decision aid to discern patients without and with midfacial and mandibular fractures that require treatment (the REDUCTION-II study): a prospective multicentre cohort study. Eur J Trauma Emerg Surg. 2022 Aug;48(4):2547-2558. doi: 10.1007/s00068-022-01892-4. Epub 2022 Feb 24.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2018
Primary Completion (Actual)
September 30, 2019
Study Completion (Actual)
June 1, 2021
Study Registration Dates
First Submitted
October 4, 2017
First Submitted That Met QC Criteria
October 18, 2017
First Posted (Actual)
October 19, 2017
Study Record Updates
Last Update Posted (Actual)
May 23, 2022
Last Update Submitted That Met QC Criteria
May 20, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201700304
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Craniocerebral Trauma
-
Nanjing Yoko Biomedical Co., Ltd.Recruiting
-
Assistance Publique - Hôpitaux de ParisFrancophone Pediatric Resuscitation and Emergency Group (GFRUP)Completed
-
University Hospital, ToulouseNot yet recruiting
-
Marmara UniversityCompleted
-
Methodist Health SystemRecruiting
-
Centre Hospitalier Annecy GenevoisTerminated
-
Rabin Medical CenterIsraeli Ministry of SecurityUnknown
-
University Hospital, AngersRecruiting
-
University of North Carolina, Chapel HillUnited States Department of DefenseRecruiting
Clinical Trials on Standardized physical examination
-
Karolinska InstitutetLund UniversityCompleted
-
KU LeuvenUnknownPatients With Adnexal Mass Prior to SurgeryBelgium
-
KU LeuvenUnknownPneumonia, Viral | Pneumonia | Pregnancy Related | Pregnancy, High Risk | COVID | Diagnoses Disease | Pregnancy Complications, Infectious | Pregnancy DiseaseBelgium, Italy, United Kingdom
-
National Taiwan University HospitalNot yet recruitingEducation, MedicalTaiwan
-
William Beaumont HospitalsCompleted
-
Institut Pasteur de LilleNational Center for Precision Diabetic Medicine,PreciDIABRecruiting
-
University of Alabama at BirminghamWashington University Early Recognition CenterCompleted
-
David FinchLancashire Teaching Hospitals NHS Foundation TrustNot yet recruitingAnal Intraepithelial Neoplasia | Anal High-grade Squamous Intraepithelial Lesion | Anal HSIL
-
Assiut UniversityNot yet recruitingCongenital Heart Disease
-
University of RochesterCompletedPelvic Organ ProlapseUnited States